{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T20:50:43Z","timestamp":1791665443681,"version":"4.3.4"},"reference-count":173,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003030","name":"AGAUR","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008061","name":"Fundaci\u00f3n Mutua Madrile\u00f1a","doi-asserted-by":"publisher","award":["AP180672022"],"award-info":[{"award-number":["AP180672022"]}],"id":[{"id":"10.13039\/100008061","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.jhepr.2025.101704","type":"journal-article","created":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T08:02:12Z","timestamp":1764662532000},"page":"101704","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Steatotic liver disease and liver transplantation: Candidate selection and post-transplant management"],"prefix":"10.1016","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6024-8479","authenticated-orcid":false,"given":"Jordi","family":"Colmenero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1178-4897","authenticated-orcid":false,"given":"Gonzalo","family":"Crespo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Line Carolle","family":"Ntandja Wandji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4950-6988","authenticated-orcid":false,"given":"Yiliam","family":"Fundora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Louvet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jhepr.2025.101704_bib1","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.jhepr.2025.101704_bib2","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.cgh.2024.01.006","article-title":"Misclassified alcohol-related liver disease is common in presumed metabolic dysfunction-associated steatotic liver disease and highly increases risk for future cirrhosis","volume":"22","author":"Nasr","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.jhepr.2025.101704_bib3","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.jhep.2014.12.005","article-title":"Alcohol drinking pattern and risk of alcoholic liver cirrhosis: a prospective cohort study","volume":"62","author":"Askgaard","year":"2015","journal-title":"J Hepatol"},{"issue":"10","key":"10.1016\/j.jhepr.2025.101704_bib4","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.14309\/ajg.0000000000000340","article-title":"Alcohol consumption and risk of liver cirrhosis: a systematic review and meta-analysis","volume":"114","author":"Roerecke","year":"2019","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.jhepr.2025.101704_bib5","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.jhep.2024.11.028","article-title":"Metabolic dysfunction and alcohol-related liver disease (MetALD): position statement by an expert panel on alcohol-related liver disease","volume":"82","author":"Arab","year":"2025","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.jhepr.2025.101704_bib6","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.jhep.2024.06.036","article-title":"Low-to-moderate alcohol consumption is associated with increased fibrosis in individuals with metabolic dysfunction-associated steatotic liver disease","volume":"81","author":"Marti-Aguado","year":"2024","journal-title":"J Hepatol"},{"issue":"10319","key":"10.1016\/j.jhepr.2025.101704_bib7","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0140-6736(21)01701-3","article-title":"The EASL-Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality","volume":"399","author":"Karlsen","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jhepr.2025.101704_bib8","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.c1240","article-title":"Effect of body mass index and alcohol consumption on liver disease: analysis of data from two prospective cohort studies","volume":"340","author":"Hart","year":"2010","journal-title":"Bmj"},{"issue":"1","key":"10.1016\/j.jhepr.2025.101704_bib9","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jhep.2022.08.030","article-title":"Alcohol consumption and metabolic syndrome: clinical and epidemiological impact on liver disease","volume":"78","author":"\u00c5berg","year":"2023","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.jhepr.2025.101704_bib10","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1097\/HEP.0000000000000899","article-title":"Alcohol-associated liver disease-Global epidemiology","volume":"80","author":"\u00c5berg","year":"2024","journal-title":"Hepatology"},{"issue":"10347","key":"10.1016\/j.jhepr.2025.101704_bib11","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0140-6736(22)00847-9","article-title":"Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020","volume":"400","year":"2022","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.jhepr.2025.101704_bib12","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","article-title":"EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"81","year":"2024","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.jhepr.2025.101704_bib13","doi-asserted-by":"crossref","first-page":"222","DOI":"10.21037\/hbsn-24-51","article-title":"Prevalence and longitudinal effects on mortality associated with spectrum of alcohol intake in steatotic liver disease: a United States population study","volume":"14","author":"Ong","year":"2025","journal-title":"Hepatobiliary Surg Nutr"},{"issue":"2","key":"10.1016\/j.jhepr.2025.101704_bib14","doi-asserted-by":"crossref","first-page":"101250","DOI":"10.1016\/j.jhepr.2024.101250","article-title":"MetALD: clinical aspects, pathophysiology and treatment","volume":"7","author":"Gratac\u00f3s-Gin\u00e8s","year":"2025","journal-title":"JHEP Rep"},{"issue":"1","key":"10.1016\/j.jhepr.2025.101704_bib15","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.54707","article-title":"Estimated burden of metabolic dysfunction-associated steatotic liver disease in US adults, 2020 to 2050","volume":"8","author":"Le","year":"2025","journal-title":"JAMA Netw Open"},{"issue":"6","key":"10.1016\/j.jhepr.2025.101704_bib16","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.jhep.2024.07.032","article-title":"EASL clinical practice guidelines on liver transplantation","volume":"81","year":"2024","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.jhepr.2025.101704_bib17","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1001\/jamainternmed.2018.6536","article-title":"National trends and long-term outcomes of liver transplant for alcohol-associated liver disease in the United States","volume":"179","author":"Lee","year":"2019","journal-title":"JAMA Intern Med"},{"issue":"9","key":"10.1016\/j.jhepr.2025.101704_bib18","article-title":"Waiting list mortality and 5-year transplant survival benefit of patients with MASLD: an Italian liver transplant registry study","volume":"6","author":"Vitale","year":"2024","journal-title":"JHEP Rep"},{"issue":"1","key":"10.1016\/j.jhepr.2025.101704_bib19","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/TP.0000000000002484","article-title":"Epidemiology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: implications for liver transplantation","volume":"103","author":"Younossi","year":"2019","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.jhepr.2025.101704_bib20","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1097\/HEP.0000000000000914","article-title":"Waitlisting and liver transplantation for MetALD in the United States: an analysis of the UNOS national registry","volume":"81","author":"Ochoa-Allemant","year":"2025","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.jhepr.2025.101704_bib21","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000352","article-title":"The changing epidemiology of adult liver transplantation in the United States in 2013-2022: the dominance of metabolic dysfunction-associated steatotic liver disease and alcohol-associated liver disease","volume":"8","author":"Younossi","year":"2024","journal-title":"Hepatol Commun"},{"issue":"1","key":"10.1016\/j.jhepr.2025.101704_bib22","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/ijc.35097","article-title":"Metabolic dysfunction-associated steatotic liver disease has become the most common cause of hepatocellular carcinoma in Sweden: a nationwide cohort study","volume":"156","author":"Vaz","year":"2025","journal-title":"Int J Cancer"},{"issue":"2","key":"10.1016\/j.jhepr.2025.101704_bib23","doi-asserted-by":"crossref","first-page":"410","DOI":"10.14309\/ajg.0000000000002920","article-title":"Liver cancer risk across metabolic dysfunction-associated steatotic liver disease and\/or alcohol: a nationwide study","volume":"120","author":"Yun","year":"2025","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhepr.2025.101704_bib24","article-title":"Steatotic liver disease is the dominant indication for liver transplantation in both Europe and the United States: trends and outcomes in the past 2 decades","author":"Younossi","year":"2025","journal-title":"Liver Transpl"},{"issue":"10","key":"10.1016\/j.jhepr.2025.101704_bib25","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1111\/liv.15676","article-title":"Hepatic recompensation according to Baveno VII criteria is linked to a significant survival benefit in decompensated alcohol-related cirrhosis","volume":"43","author":"Hofer","year":"2023","journal-title":"Liver Int"},{"issue":"9","key":"10.1016\/j.jhepr.2025.101704_bib26","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1002\/lt.25485","article-title":"Superior wait-list outcomes in patients with alcohol-associated liver disease compared with other indications for liver transplantation","volume":"25","author":"Giard","year":"2019","journal-title":"Liver Transpl"},{"issue":"2","key":"10.1016\/j.jhepr.2025.101704_bib27","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jhep.2021.02.033","article-title":"A notable proportion of liver transplant candidates with alcohol-related cirrhosis can be delisted because of clinical improvement","volume":"75","author":"Pose","year":"2021","journal-title":"J Hepatol"},{"issue":"8","key":"10.1016\/j.jhepr.2025.101704_bib28","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1002\/lt.25460","article-title":"Prediction of alcohol relapse among liver transplant candidates with less than 6 Months of abstinence using the high-risk alcoholism relapse score","volume":"25","author":"Lombardo-Quezada","year":"2019","journal-title":"Liver Transpl"},{"issue":"11","key":"10.1016\/j.jhepr.2025.101704_bib29","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S2468-1253(21)00195-3","article-title":"Liver transplantation for alcohol-related liver disease in the UK: revised UK Liver Advisory Group recommendations for referral","volume":"6","author":"Masson","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"12","key":"10.1016\/j.jhepr.2025.101704_bib30","first-page":"661","article-title":"Early liver transplantation in severe alcohol-associated hepatitis","volume":"116","author":"Colmenero","year":"2024","journal-title":"Rev Esp Enferm Dig"},{"issue":"1","key":"10.1016\/j.jhepr.2025.101704_bib31","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jhep.2018.03.018","article-title":"EASL clinical practice guidelines: management of alcohol-related liver disease","volume":"69","year":"2018","journal-title":"J Hepatol"},{"issue":"11","key":"10.1016\/j.jhepr.2025.101704_bib32","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1001\/jamasurg.2021.3748","article-title":"Evaluation of early vs standard liver transplant for alcohol-associated liver disease","volume":"156","author":"Herrick-Reynolds","year":"2021","journal-title":"JAMA Surg"},{"issue":"6","key":"10.1016\/j.jhepr.2025.101704_bib33","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1053\/j.gastro.2021.08.004","article-title":"Results of early transplantation for alcohol-related cirrhosis: integrated addiction treatment with low rate of relapse","volume":"161","author":"Carrique","year":"2021","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.jhepr.2025.101704_bib34","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/j.1572-0241.2007.01691.x","article-title":"A critical review of candidacy for orthotopic liver transplantation in alcoholic liver disease","volume":"103","author":"Kotlyar","year":"2008","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.jhepr.2025.101704_bib35","doi-asserted-by":"crossref","first-page":"e119","DOI":"10.1097\/ADM.0000000000001084","article-title":"Simultaneous management of alcohol use disorder and liver disease: a systematic review and meta-analysis","volume":"17","author":"Elfeki","year":"2023","journal-title":"J Addict Med"},{"issue":"8","key":"10.1016\/j.jhepr.2025.101704_bib36","doi-asserted-by":"crossref","first-page":"503","DOI":"10.7326\/0003-4819-155-8-201110180-00006","article-title":"Decision making in liver transplant selection committees: a multicenter study","volume":"155","author":"Volk","year":"2011","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.jhepr.2025.101704_bib37","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1002\/hep.21607","article-title":"The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids","volume":"45","author":"Louvet","year":"2007","journal-title":"Hepatology"},{"issue":"19","key":"10.1016\/j.jhepr.2025.101704_bib38","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1056\/NEJMoa1105703","article-title":"Early liver transplantation for severe alcoholic hepatitis","volume":"365","author":"Mathurin","year":"2011","journal-title":"N Engl J Med"},{"issue":"26","key":"10.1016\/j.jhepr.2025.101704_bib39","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1056\/NEJMra2207599","article-title":"Alcohol-associated hepatitis","volume":"387","author":"Bataller","year":"2022","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.jhepr.2025.101704_bib40","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S2468-1253(21)00430-1","article-title":"Early liver transplantation for severe alcohol-related hepatitis not responding to medical treatment: a prospective controlled study","volume":"7","author":"Louvet","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.jhepr.2025.101704_bib41","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1111\/ajt.13586","article-title":"Early liver transplantation for severe alcoholic hepatitis in the United States--A single-center experience","volume":"16","author":"Im","year":"2016","journal-title":"Am J Transpl"},{"issue":"2","key":"10.1016\/j.jhepr.2025.101704_bib42","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1053\/j.gastro.2018.04.009","article-title":"Outcomes of early liver transplantation for patients with severe alcoholic hepatitis","volume":"155","author":"Lee","year":"2018","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.jhepr.2025.101704_bib43","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.jamcollsurg.2017.12.044","article-title":"Liver transplantation for severe alcoholic hepatitis, updated lessons from the world's largest series","volume":"226","author":"Weeks","year":"2018","journal-title":"J Am Coll Surg"},{"issue":"10","key":"10.1016\/j.jhepr.2025.101704_bib44","doi-asserted-by":"crossref","first-page":"3527","DOI":"10.1016\/j.transproceed.2018.08.057","article-title":"Liver transplantation for severe alcoholic hepatitis: report of a single center pilot program","volume":"50","author":"Sundaram","year":"2018","journal-title":"Transpl Proc"},{"issue":"3","key":"10.1016\/j.jhepr.2025.101704_bib45","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1111\/ajt.16143","article-title":"Liver transplantation for alcoholic hepatitis in the United States: excellent outcomes with profound temporal and geographic variation in frequency","volume":"21","author":"Cotter","year":"2021","journal-title":"Am J Transpl"},{"issue":"2","key":"10.1016\/j.jhepr.2025.101704_bib46","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.cgh.2020.11.024","article-title":"Patterns of alcohol use after early liver transplantation for alcoholic hepatitis","volume":"20","author":"Lee","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"12","key":"10.1016\/j.jhepr.2025.101704_bib47","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.14309\/ajg.0000000000001901","article-title":"Early liver transplantation for severe alcohol-associated hepatitis and a history of prior liver decompensation","volume":"117","author":"Weinberg","year":"2022","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.jhepr.2025.101704_bib48","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1111\/ajt.16936","article-title":"Liver transplantation for severe alcoholic hepatitis: a multicenter Italian study","volume":"22","author":"Germani","year":"2022","journal-title":"Am J Transpl"},{"issue":"4","key":"10.1016\/j.jhepr.2025.101704_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2023.101098","article-title":"Early living donor liver transplantation for alcohol-associated hepatitis","volume":"28","author":"Kulkarni","year":"2023","journal-title":"Ann Hepatol"},{"issue":"10152","key":"10.1016\/j.jhepr.2025.101704_bib50","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S0140-6736(18)31310-2","article-title":"Alcohol use and burden for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"392","year":"2018","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.jhepr.2025.101704_bib51","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jhep.2015.10.006","article-title":"EASL clinical practice guidelines: liver transplantation","volume":"64","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2025.101704_bib52","article-title":"Association between clinically recorded alcohol consumption and initial presentation of 12 cardiovascular diseases: population based cohort study using linked health records","volume":"356","author":"Bell","year":"2017","journal-title":"Bmj"},{"issue":"4","key":"10.1016\/j.jhepr.2025.101704_bib53","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.jhep.2017.06.009","article-title":"Liver transplantation in the most severely ill cirrhotic patients: a multicenter study in acute-on-chronic liver failure grade 3","volume":"67","author":"Artru","year":"2017","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.jhepr.2025.101704_bib54","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jhepr.2019.02.008","article-title":"Approaches for patients with very high MELD scores","volume":"1","author":"Artru","year":"2019","journal-title":"JHEP Rep"},{"issue":"2","key":"10.1016\/j.jhepr.2025.101704_bib55","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1053\/j.gastro.2009.04.062","article-title":"Infection in patients with severe alcoholic hepatitis treated with steroids: early response to therapy is the key factor","volume":"137","author":"Louvet","year":"2009","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.jhepr.2025.101704_bib56","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jhep.2023.04.021","article-title":"EASL Clinical Practice Guidelines on acute-on-chronic liver failure","volume":"79","author":"Liver","year":"2023","journal-title":"J Hepatol"},{"issue":"12","key":"10.1016\/j.jhepr.2025.101704_bib57","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1111\/liv.15726","article-title":"Patients hospitalized with alcohol-related liver disease and prior bariatric surgery are more prone to develop acute-on-chronic liver failure","volume":"43","author":"Onghena","year":"2023","journal-title":"Liver Int"},{"issue":"3","key":"10.1016\/j.jhepr.2025.101704_bib58","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/jgh.13166","article-title":"Nonalcoholic steatohepatitis is strongly associated with sarcopenic obesity in patients with cirrhosis undergoing liver transplant evaluation","volume":"31","author":"Carias","year":"2016","journal-title":"J Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.jhepr.2025.101704_bib59","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1111\/ajt.17079","article-title":"Sarcopenic visceral obesity is associated with increased post-liver transplant mortality in acutely ill patients with cirrhosis","volume":"22","author":"Ha","year":"2022","journal-title":"Am J Transpl"},{"issue":"10","key":"10.1016\/j.jhepr.2025.101704_bib60","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.14309\/ajg.0000000000001376","article-title":"Prehabilitation-driven changes in frailty metrics predict mortality in patients with advanced liver disease","volume":"116","author":"Lin","year":"2021","journal-title":"Am J Gastroenterol"},{"issue":"10464","key":"10.1016\/j.jhepr.2025.101704_bib61","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/S0140-6736(24)01811-7","article-title":"Steatotic liver disease","volume":"404","author":"Israelsen","year":"2024","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.jhepr.2025.101704_bib62","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11041110","article-title":"Comorbidities and malignancy among NAFLD patients compared to the general population, A nation-based study","volume":"11","author":"Abu-Freha","year":"2023","journal-title":"Biomedicines"},{"issue":"12","key":"10.1016\/j.jhepr.2025.101704_bib63","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1016\/j.cgh.2021.12.002","article-title":"2019 global NAFLD prevalence: a systematic review and meta-analysis","volume":"20","author":"Le","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.jhepr.2025.101704_bib64","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/LVT.0000000000000013","article-title":"Evolution of pretransplant cardiac risk factor burden and major adverse cardiovascular events in liver transplant recipients over time","volume":"29","author":"Harrington","year":"2023","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhepr.2025.101704_bib65","doi-asserted-by":"crossref","DOI":"10.1097\/LVT.0000000000000609","article-title":"Optimizing liver transplant candidacy in patients with cirrhosis and obesity","author":"Ha","year":"2025","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhepr.2025.101704_bib66","doi-asserted-by":"crossref","DOI":"10.1097\/LVT.0000000000000645","article-title":"Management of obesity in liver transplant candidates & recipients: rethinking the false dichotomy between pharmacotherapy and surgical intervention","author":"Davis","year":"2025","journal-title":"Liver Transpl"},{"issue":"11","key":"10.1016\/j.jhepr.2025.101704_bib67","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1097\/TP.0000000000005070","article-title":"Successful implementation of a multidisciplinary weight loss program including GLP1 receptor agonists for liver transplant candidates with high body mass index","volume":"108","author":"Gonzalez","year":"2024","journal-title":"Transplantation"},{"issue":"9","key":"10.1016\/j.jhepr.2025.101704_bib68","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1002\/lt.26074","article-title":"Efficacy and safety of endoscopic balloon placement for weight loss in patients with cirrhosis awaiting liver transplantation","volume":"27","author":"Watt","year":"2021","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhepr.2025.101704_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2025.02.030","article-title":"Simultaneous liver transplant and sleeve gastrectomy provides durable weight loss, improves metabolic syndrome and reduces allograft steatosis","author":"Larson","year":"2025","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.jhepr.2025.101704_bib70","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1097\/LVT.0000000000000522","article-title":"Safety and efficacy of simultaneous liver transplantation and sleeve gastrectomy in morbid obese patients with end-stage liver disease: the LT-SG study","volume":"31","author":"Manzia","year":"2025","journal-title":"Liver Transpl"},{"issue":"4","key":"10.1016\/j.jhepr.2025.101704_bib71","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1097\/TP.0000000000004402","article-title":"Outcomes of liver transplantation in patients with preexisting coronary artery disease","volume":"107","author":"Reznicek","year":"2023","journal-title":"Transplantation"},{"issue":"10","key":"10.1016\/j.jhepr.2025.101704_bib72","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1002\/lt.25613","article-title":"The impact of coronary artery disease and statins on survival after liver transplantation","volume":"25","author":"Patel","year":"2019","journal-title":"Liver Transpl"},{"issue":"8","key":"10.1016\/j.jhepr.2025.101704_bib73","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1111\/liv.15926","article-title":"CACS, CCTA and mCAD-LT score in the pre-transplant assessment of coronary artery disease and the prediction of post-transplant cardiovascular events","volume":"44","author":"Pagano","year":"2024","journal-title":"Liver Int"},{"issue":"21","key":"10.1016\/j.jhepr.2025.101704_bib74","doi-asserted-by":"crossref","first-page":"e299","DOI":"10.1161\/CIR.0000000000001104","article-title":"Emerging evidence on coronary heart disease screening in kidney and liver transplantation candidates: a scientific statement from the American heart association: endorsed by the American society of transplantation","volume":"146","author":"Cheng","year":"2022","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.jhepr.2025.101704_bib75","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.jhep.2023.03.023","article-title":"Evaluation of recipients with significant comorbidity - patients with cardiovascular disease","volume":"78","author":"Tsochatzis","year":"2023","journal-title":"J Hepatol"},{"issue":"41","key":"10.1016\/j.jhepr.2025.101704_bib76","doi-asserted-by":"crossref","first-page":"4399","DOI":"10.1093\/eurheartj\/ehae502","article-title":"Cardiovascular disease assessment and management in liver transplantation","volume":"45","author":"Harinstein","year":"2024","journal-title":"Eur Heart J"},{"issue":"12","key":"10.1016\/j.jhepr.2025.101704_bib77","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1097\/LVT.0000000000000396","article-title":"Management of the liver transplant candidate with high cardiac risk: multidisciplinary best practices and recommendations","volume":"30","author":"Pagano","year":"2024","journal-title":"Liver Transpl"},{"issue":"13","key":"10.1016\/j.jhepr.2025.101704_bib78","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1161\/CIRCULATIONAHA.108.847178","article-title":"Perioperative risk predictors of cardiac outcomes in patients undergoing liver transplantation surgery","volume":"120","author":"Safadi","year":"2009","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.jhepr.2025.101704_bib79","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1002\/lt.22152","article-title":"Multivessel coronary artery disease predicts mortality, length of stay, and pressor requirements after liver transplantation","volume":"16","author":"Yong","year":"2010","journal-title":"Liver Transpl"},{"issue":"1","key":"10.1016\/j.jhepr.2025.101704_bib80","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/hep.31023","article-title":"Pre-liver transplant cardiac catheterization is associated with low rate of myocardial infarction and cardiac mortality","volume":"72","author":"Kutkut","year":"2020","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.jhepr.2025.101704_bib81","article-title":"Safety, efficacy, and outcomes of invasive coronary angiography in liver transplant candidates Original","volume":"7","author":"Ginard","year":"2025","journal-title":"JHEP Rep"},{"issue":"1","key":"10.1016\/j.jhepr.2025.101704_bib82","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jhep.2021.01.008","article-title":"CAD-LT score effectively predicts risk of significant coronary artery disease in liver transplant candidates","volume":"75","author":"Rachwan","year":"2021","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.jhepr.2025.101704_bib83","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jhep.2018.03.018","article-title":"EASL clinical practice guidelines: management of alcohol-related liver disease","volume":"69","year":"2018","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.jhepr.2025.101704_bib84","first-page":"79","article-title":"Frequency of cardiovascular events and effect on survival in liver transplant recipients for cirrhosis due to alcoholic or nonalcoholic steatohepatitis","volume":"14","author":"Piazza","year":"2016","journal-title":"Exp Clin Transpl"},{"issue":"10","key":"10.1016\/j.jhepr.2025.101704_bib85","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1111\/j.1600-6143.2010.03232.x","article-title":"Trajectories of alcohol consumption following liver transplantation","volume":"10","author":"DiMartini","year":"2010","journal-title":"Am J Transpl"},{"issue":"5","key":"10.1016\/j.jhepr.2025.101704_bib86","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1111\/j.1572-0241.2007.01079.x","article-title":"Negative impact of de novo malignancies rather than alcohol relapse on survival after liver transplantation for alcoholic cirrhosis: a retrospective analysis of 305 patients in a single center","volume":"102","author":"Dumortier","year":"2007","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.jhepr.2025.101704_bib87","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1053\/j.gastro.2009.08.070","article-title":"Long-term probability of and mortality from de novo malignancy after liver transplantation","volume":"137","author":"Watt","year":"2009","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.jhepr.2025.101704_bib88","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1097\/TP.0000000000003998","article-title":"De novo malignancy after liver transplantation: risk assessment, prevention, and management-guidelines from the ILTS-SETH consensus conference","volume":"106","author":"Colmenero","year":"2022","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.jhepr.2025.101704_bib89","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1111\/ajt.17021","article-title":"Cumulative exposure to tacrolimus and incidence of cancer after liver transplantation","volume":"22","author":"Rodr\u00edguez-Per\u00e1lvarez","year":"2022","journal-title":"Am J Transpl"},{"key":"10.1016\/j.jhepr.2025.101704_bib90","doi-asserted-by":"crossref","first-page":"30","DOI":"10.21037\/tgh.2019.11.18","article-title":"Post-transplant malignancies in alcoholic liver disease","volume":"5","author":"Singh","year":"2020","journal-title":"Transl Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.jhepr.2025.101704_bib91","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1053\/j.gastro.2019.04.012","article-title":"Model to calculate harms and benefits of early vs delayed liver transplantation for patients with alcohol-associated hepatitis","volume":"157","author":"Lee","year":"2019","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.jhepr.2025.101704_bib92","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1002\/lt.23762","article-title":"Abusive drinking after liver transplantation is associated with allograft loss and advanced allograft fibrosis","volume":"19","author":"Rice","year":"2013","journal-title":"Liver Transpl"},{"issue":"2","key":"10.1016\/j.jhepr.2025.101704_bib93","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jhep.2012.03.014","article-title":"Excessive alcohol consumption after liver transplantation impacts on long-term survival, whatever the primary indication","volume":"57","author":"Faure","year":"2012","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.jhepr.2025.101704_bib94","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0005-7967(79)90025-1","article-title":"Reliability of alcohol abusers\u2019 self-reports of drinking behavior","volume":"17","author":"Sobell","year":"1979","journal-title":"Behav Res Ther"},{"issue":"1","key":"10.1016\/j.jhepr.2025.101704_bib95","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/acer.13276","article-title":"Follow-up of alcohol consumption after liver transplantation: interest of an addiction team?","volume":"41","author":"Donnadieu-Rigole","year":"2017","journal-title":"Alcohol Clin Exp Res"},{"issue":"9","key":"10.1016\/j.jhepr.2025.101704_bib96","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1111\/acer.12117","article-title":"Liver transplantation in alcoholic patients: impact of an alcohol addiction unit within a liver transplant center","volume":"37","author":"Addolorato","year":"2013","journal-title":"Alcohol Clin Exp Res"},{"issue":"5","key":"10.1016\/j.jhepr.2025.101704_bib97","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1002\/hep.24596","article-title":"Urinary ethyl glucuronide as a novel screening tool in patients pre- and post-liver transplantation improves detection of alcohol consumption","volume":"54","author":"Staufer","year":"2011","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.jhepr.2025.101704_bib98","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/liv.12243","article-title":"Determination of ethyl glucuronide in hair improves evaluation of long-term alcohol abstention in liver transplant candidates","volume":"34","author":"Sterneck","year":"2014","journal-title":"Liver Int"},{"issue":"1","key":"10.1016\/j.jhepr.2025.101704_bib99","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/acer.14512","article-title":"Diagnostic accuracy of biomarkers of alcohol use in patients with liver disease: a systematic review","volume":"45","author":"Arnts","year":"2021","journal-title":"Alcohol Clin Exp Res"},{"issue":"6","key":"10.1016\/j.jhepr.2025.101704_bib100","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/tri.12949","article-title":"Improved detection of alcohol consumption using the novel marker phosphatidylethanol in the transplant setting: results of a prospective study","volume":"30","author":"Andresen-Streichert","year":"2017","journal-title":"Transpl Int"},{"issue":"1","key":"10.1016\/j.jhepr.2025.101704_bib101","doi-asserted-by":"crossref","first-page":"30","DOI":"10.14309\/ajg.0000000000002572","article-title":"ACG clinical guideline: alcohol-associated liver disease","volume":"119","author":"Jophlin","year":"2024","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.jhepr.2025.101704_bib102","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1111\/acer.14611","article-title":"Factors associated with phosphatidylethanol (PEth) sensitivity for detecting unhealthy alcohol use: an individual patient data meta-analysis","volume":"45","author":"Hahn","year":"2021","journal-title":"Alcohol Clin Exp Res"},{"issue":"3","key":"10.1016\/j.jhepr.2025.101704_bib103","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1053\/jlts.2001.22326","article-title":"Employment and alcohol use after liver transplantation for alcoholic and nonalcoholic liver disease: a systematic review","volume":"7","author":"Bravata","year":"2001","journal-title":"Liver Transpl"},{"issue":"10","key":"10.1016\/j.jhepr.2025.101704_bib104","article-title":"Integrating an addiction team into the management of patients transplanted for alcohol-associated liver disease reduces the risk of severe relapse","volume":"5","author":"Daniel","year":"2023","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhepr.2025.101704_bib105","doi-asserted-by":"crossref","DOI":"10.1002\/hep.31731","article-title":"De novo colorectal and pancreatic cancer in liver transplant recipients: identifying the higher risk populations","author":"Nasser-Ghodsi","year":"2021","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.jhepr.2025.101704_bib106","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.14714","article-title":"Increasing nonalcoholic steatohepatitis overlap in liver transplant recipients: Additive risk for de novo malignancy","volume":"36","author":"Nasser-Ghodsi","year":"2022","journal-title":"Clin Transpl"},{"issue":"4","key":"10.1016\/j.jhepr.2025.101704_bib107","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/LVT.0000000000000060","article-title":"Hepatic steatosis after liver transplantation: a systematic review and meta-analysis","volume":"29","author":"Silva","year":"2023","journal-title":"Liver Transpl"},{"issue":"11","key":"10.1016\/j.jhepr.2025.101704_bib108","doi-asserted-by":"crossref","first-page":"e345","DOI":"10.1097\/TP.0000000000002916","article-title":"Incidence and risks for nonalcoholic fatty liver disease and steatohepatitis post-liver transplant: systematic review and meta-analysis","volume":"103","author":"Saeed","year":"2019","journal-title":"Transplantation"},{"issue":"10","key":"10.1016\/j.jhepr.2025.101704_bib109","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/s41574-022-00711-5","article-title":"Metabolic mechanisms for and treatment of NAFLD or NASH occurring after liver transplantation","volume":"18","author":"Lonardo","year":"2022","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"10.1016\/j.jhepr.2025.101704_bib110","article-title":"Inevitability of disease recurrence after liver transplantation for NAFLD cirrhosis","volume":"5","author":"Villeret","year":"2023","journal-title":"JHEP Rep"},{"issue":"5","key":"10.1016\/j.jhepr.2025.101704_bib111","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.jceh.2023.03.013","article-title":"NASH after liver transplantation: impact of immunosuppression","volume":"13","author":"Taneja","year":"2023","journal-title":"J Clin Exp Hepatol"},{"issue":"7","key":"10.1016\/j.jhepr.2025.101704_bib112","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1097\/MEG.0000000000001105","article-title":"De-novo nonalcoholic steatohepatitis is associated with long-term increased mortality in liver transplant recipients","volume":"30","author":"Gitto","year":"2018","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.jhepr.2025.101704_bib113","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1053\/jlts.2001.25453","article-title":"Frequency of nonalcoholic steatohepatitis as a cause of advanced liver disease","volume":"7","author":"Charlton","year":"2001","journal-title":"Liver Transpl"},{"issue":"3","key":"10.1016\/j.jhepr.2025.101704_bib114","doi-asserted-by":"crossref","first-page":"E162","DOI":"10.1111\/hepr.12940","article-title":"Effect of PNPLA3 I148M polymorphism on histologically proven non-alcoholic fatty liver disease in liver transplant recipients","volume":"48","author":"Kim","year":"2018","journal-title":"Hepatol Res"},{"issue":"12","key":"10.1016\/j.jhepr.2025.101704_bib115","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.14093","article-title":"Association between obesity after liver transplantation and steatosis, inflammation, and fibrosis of the graft","volume":"34","author":"Dobrindt","year":"2020","journal-title":"Clin Transpl"},{"issue":"3","key":"10.1016\/j.jhepr.2025.101704_bib116","doi-asserted-by":"crossref","first-page":"129","DOI":"10.14744\/hf.2023.2023.0032","article-title":"Prevalence and predictors of metabolic-associated fatty liver disease in liver transplant recipients: a cross-sectional prospective study","volume":"4","author":"Adali","year":"2023","journal-title":"Hepatol Forum"},{"issue":"5","key":"10.1016\/j.jhepr.2025.101704_bib117","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/j.jceh.2022.04.012","article-title":"Nonalcoholic fatty liver disease in living donor liver transplant recipients: a histology-based study","volume":"12","author":"Choudhary","year":"2022","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.jhepr.2025.101704_bib118","article-title":"Assessment of steatosis and fibrosis in liver transplant recipients using controlled attenuation parameter and liver stiffness measurements","volume":"2021","author":"Mikolasevic","year":"2021","journal-title":"Can J Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.jhepr.2025.101704_bib119","doi-asserted-by":"crossref","first-page":"932","DOI":"10.5604\/01.3001.0010.5285","article-title":"New onset diabetes and non-alcoholic fatty liver disease after liver transplantation","volume":"16","author":"Andrade","year":"2017","journal-title":"Ann Hepatol"},{"issue":"13","key":"10.1016\/j.jhepr.2025.101704_bib120","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13133871","article-title":"Metabolic-dysfunction-associated steatotic liver disease (MASLD) after liver transplantation: a narrative review of an emerging issue","volume":"13","author":"Savino","year":"2024","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.jhepr.2025.101704_bib121","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/TP.0000000000002485","article-title":"Management of recurrent and de novo NAFLD\/NASH after liver transplantation","volume":"103","author":"Germani","year":"2019","journal-title":"Transplantation"},{"issue":"12","key":"10.1016\/j.jhepr.2025.101704_bib122","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1016\/j.cgh.2013.06.025","article-title":"Patatin-like phospholipase domain-containing protein 3 rs738409-G in recipients of liver transplants is a risk factor for graft steatosis","volume":"11","author":"Finkenstedt","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.jhepr.2025.101704_bib123","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1111\/ajt.12355","article-title":"Investigation of PNPLA3 and IL28B genotypes on diabetes and obesity after liver transplantation: insight into mechanisms of disease","volume":"13","author":"Watt","year":"2013","journal-title":"Am J Transpl"},{"key":"10.1016\/j.jhepr.2025.101704_bib124","article-title":"Metabolic issues in patients with metabolic dysfunction-associated steatohepatitis (MASH) and their impact on MASH recurrence following liver transplantation: a narrative review","author":"Alnimer","year":"2024","journal-title":"Liver Transpl"},{"issue":"2","key":"10.1016\/j.jhepr.2025.101704_bib125","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/TP.0000000000002852","article-title":"Incidence, predictors, and impact on survival of long-term cardiovascular events after liver transplantation","volume":"104","author":"Sastre","year":"2020","journal-title":"Transplantation"},{"issue":"9","key":"10.1016\/j.jhepr.2025.101704_bib126","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1111\/ajt.13779","article-title":"Factors associated with major adverse cardiovascular events after liver transplantation among a national sample","volume":"16","author":"VanWagner","year":"2016","journal-title":"Am J Transpl"},{"issue":"7","key":"10.1016\/j.jhepr.2025.101704_bib127","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1097\/TP.0000000000001710","article-title":"Incidence of and risk assessment for adverse cardiovascular outcomes after liver transplantation: a systematic review","volume":"101","author":"Konerman","year":"2017","journal-title":"Transplantation"},{"issue":"7","key":"10.1016\/j.jhepr.2025.101704_bib128","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1097\/TP.0000000000002175","article-title":"Cardiovascular disease outcomes related to early stage renal impairment after liver transplantation","volume":"102","author":"VanWagner","year":"2018","journal-title":"Transplantation"},{"issue":"8","key":"10.1016\/j.jhepr.2025.101704_bib129","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1002\/lt.26443","article-title":"Results of a multidisciplinary strategy to improve the management of cardiovascular risk factors after liver transplantation","volume":"28","author":"Sastre","year":"2022","journal-title":"Liver Transpl"},{"issue":"8","key":"10.1016\/j.jhepr.2025.101704_bib130","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1097\/TP.0000000000004875","article-title":"Minimizing metabolic and cardiac risk factors to maximize outcomes after liver transplantation","volume":"108","author":"Schmidt","year":"2024","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.jhepr.2025.101704_bib131","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1002\/hep4.1876","article-title":"Personalizing diabetes management in liver transplant recipients: the new era for optimizing risk management","volume":"6","author":"Richardson","year":"2022","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jhepr.2025.101704_bib132","first-page":"222","volume":"2","author":"Davis","year":"2025","journal-title":"Liver Transpl \u00a9 2025 Am Assoc Study Liver Dis"},{"issue":"2","key":"10.1016\/j.jhepr.2025.101704_bib133","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s10620-019-05800-6","article-title":"Office-based weight loss counseling is ineffective in liver transplant recipients","volume":"65","author":"Patel","year":"2020","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhepr.2025.101704_bib134","doi-asserted-by":"crossref","DOI":"10.1097\/TP.0000000000005361","article-title":"Impact of glucagon-like peptide-1 receptor agonists on metabolic health in liver transplant recipients","author":"Yakubu","year":"2025","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.jhepr.2025.101704_bib135","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2025.101920","article-title":"Semaglutide for the treatment of post transplantation diabetes mellitus in patients following liver transplantation is safe and effective","volume":"30","author":"Bot","year":"2025","journal-title":"Ann Hepatol"},{"issue":"2","key":"10.1016\/j.jhepr.2025.101704_bib136","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/LVT.0000000000000247","article-title":"Semaglutide is effective in achieving weight loss in liver transplant recipients","volume":"30","author":"Chow","year":"2024","journal-title":"Liver Transpl"},{"issue":"2","key":"10.1016\/j.jhepr.2025.101704_bib137","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/LVT.0000000000000233","article-title":"Utility of glucagon-like peptide 1 receptor agonists as anti-obesity medications in liver transplant recipients","volume":"30","author":"Richardson","year":"2024","journal-title":"Liver Transpl"},{"issue":"11","key":"10.1016\/j.jhepr.2025.101704_bib138","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1002\/lt.25637","article-title":"Delayed sleeve gastrectomy following liver transplantation: a 5-year experience","volume":"25","author":"Morris","year":"2019","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhepr.2025.101704_bib139","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehaf190","article-title":"2025 focused update of the 2019 ESC\/EAS guidelines for the management of dyslipidaemias","author":"Mach","year":"2025","journal-title":"Eur Heart J"},{"issue":"10","key":"10.1016\/j.jhepr.2025.101704_bib140","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.jacc.2019.03.009","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: executive summary: a report of the American college of cardiology\/American heart association task force on clinical practice guidelines","volume":"74","author":"Arnett","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.jhepr.2025.101704_bib141","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/TP.0000000000004291","article-title":"Impact of donor liver macrovesicular steatosis on deceased donor yield and posttransplant outcome","volume":"107","author":"Kwong","year":"2023","journal-title":"Transplantation"},{"issue":"9","key":"10.1016\/j.jhepr.2025.101704_bib142","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25094648","article-title":"Steatotic donor transplant livers: preservation strategies to mitigate against ischaemia-reperfusion injury","volume":"25","author":"Abbas","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"35","key":"10.1016\/j.jhepr.2025.101704_bib143","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000012026","article-title":"Short-term and long-term outcomes of liver transplantation using moderately and severely steatotic donor livers: a systematic review","volume":"97","author":"Wu","year":"2018","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"10.1016\/j.jhepr.2025.101704_bib144","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.jhep.2025.01.042","article-title":"Deceased donor liver utilisation and assessment: consensus guidelines from the European liver and intestine transplant association","volume":"82","author":"Hessheimer","year":"2025","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.jhepr.2025.101704_bib145","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/lt.26571","article-title":"Practice patterns of the medical evaluation of living liver donors in the United States","volume":"29","author":"Jackson","year":"2023","journal-title":"Liver Transpl"},{"issue":"3","key":"10.1016\/j.jhepr.2025.101704_bib146","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/lt.25408","article-title":"The \"skinny\" on assessment and utilization of steatotic liver grafts: a systematic review","volume":"25","author":"Croome","year":"2019","journal-title":"Liver Transpl"},{"issue":"4","key":"10.1016\/j.jhepr.2025.101704_bib147","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1002\/hep.32208","article-title":"Banff consensus recommendations for steatosis assessment in donor livers","volume":"75","author":"Neil","year":"2022","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.jhepr.2025.101704_bib148","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.jhep.2023.11.013","article-title":"Improved assessment of donor liver steatosis using Banff consensus recommendations and deep learning algorithms","volume":"80","author":"Gambella","year":"2024","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.jhepr.2025.101704_bib149","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/LVT.0000000000000467","article-title":"Development and validation of MRI-PDFF cutoffs for living liver donor eligibility assessment","volume":"31","author":"Kim","year":"2025","journal-title":"Liver Transpl"},{"issue":"4","key":"10.1016\/j.jhepr.2025.101704_bib150","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1111\/ajt.16899","article-title":"Abdominal normothermic regional perfusion in controlled donation after circulatory determination of death liver transplantation: outcomes and risk factors for graft loss","volume":"22","author":"Hessheimer","year":"2022","journal-title":"Am J Transpl"},{"issue":"7703","key":"10.1016\/j.jhepr.2025.101704_bib151","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41586-018-0047-9","article-title":"A randomized trial of normothermic preservation in liver transplantation","volume":"557","author":"Nasralla","year":"2018","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.jhepr.2025.101704_bib152","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1111\/ajt.17022","article-title":"Sequential hypothermic and normothermic machine perfusion enables safe transplantation of high-risk donor livers","volume":"22","author":"van Leeuwen","year":"2022","journal-title":"Am J Transpl"},{"issue":"1","key":"10.1016\/j.jhepr.2025.101704_bib153","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1038\/s41467-020-16251-3","article-title":"Transplantation of discarded livers following viability testing with normothermic machine perfusion","volume":"11","author":"Mergental","year":"2020","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.jhepr.2025.101704_bib154","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1097\/SLA.0000000000006047","article-title":"Defatting of Human Livers During Long-Term e x situ Normothermic Perfusion: Novel Strategy to Rescue Discarded Organs for Transplantation","volume":"278","author":"Sousa Da Silva","year":"2023","journal-title":"Ann Surg"},{"issue":"2","key":"10.1016\/j.jhepr.2025.101704_bib155","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jhep.2023.04.010","article-title":"A randomized-controlled trial of ischemia-free liver transplantation for end-stage liver disease","volume":"79","author":"Guo","year":"2023","journal-title":"J Hepatol"},{"issue":"11","key":"10.1016\/j.jhepr.2025.101704_bib156","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1111\/tri.14121","article-title":"A systematic review and meta-analyses of regional perfusion in donation after circulatory death solid organ transplantation","volume":"34","author":"De Beule","year":"2021","journal-title":"Transpl Int"},{"issue":"15","key":"10.1016\/j.jhepr.2025.101704_bib157","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1056\/NEJMoa2031532","article-title":"Hypothermic machine perfusion in liver transplantation - a randomized trial","volume":"384","author":"van Rijn","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhepr.2025.101704_bib158","article-title":"Outcomes of DCD liver transplant using sequential normothermic regional perfusion and normothermic machine perfusion or NRP alone versus static cold storage","author":"Croome","year":"2024","journal-title":"Transplantation"},{"issue":"9","key":"10.1016\/j.jhepr.2025.101704_bib159","first-page":"Cd014685","article-title":"Machine perfusion in liver transplantation","volume":"9","author":"Tingle","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"10.1016\/j.jhepr.2025.101704_bib160","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1111\/ajt.17115","article-title":"Hypothermic oxygenated perfusion in extended criteria donor liver transplantation-A randomized clinical trial","volume":"22","author":"Ravaioli","year":"2022","journal-title":"Am J Transpl"},{"issue":"5","key":"10.1016\/j.jhepr.2025.101704_bib161","first-page":"596","article-title":"Machine perfusion strategies in liver transplantation: a systematic review, pairwise, and network meta-analysis of randomized controlled trials","volume":"31","author":"Jaber","year":"2025","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhepr.2025.101704_bib162","first-page":"596","article-title":"Machine perfusion strategies in liver transplantation: a systematic review, pairwise, and network meta-analysis of randomized controlled trials. Estimated Burden of Metabolic Dysfunction-Associated Steatotic Liver Disease in US Adults, 2020 to 2050","volume":"5","author":"Jaber","year":"2025","journal-title":"Liver Transpl \u00a9 2025 Am Assoc Study Liver Dis"},{"issue":"4","key":"10.1016\/j.jhepr.2025.101704_bib163","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.jhep.2022.12.030","article-title":"A multicenter randomized-controlled trial of hypothermic oxygenated perfusion (HOPE) for human liver grafts before transplantation","volume":"78","author":"Schlegel","year":"2023","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.jhepr.2025.101704_bib164","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jhep.2024.06.035","article-title":"Long-term outcomes after hypothermic oxygenated machine perfusion and transplantation of 1,202 donor livers in a real-world setting (HOPE-REAL study)","volume":"82","author":"Eden","year":"2025","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.jhepr.2025.101704_bib165","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.ajt.2025.01.007","article-title":"Normothermic regional and ex situ perfusion reduces postreperfusion syndrome in donation after circulatory death liver transplantation: a retrospective comparative study","volume":"25","author":"Puttappa","year":"2025","journal-title":"Am J Transpl"},{"issue":"1","key":"10.1016\/j.jhepr.2025.101704_bib166","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1097\/JS9.0000000000000784","article-title":"Hypothermic oxygenated perfusion in liver transplantation: a meta-analysis of randomized controlled trials and matched studies","volume":"110","author":"Tang","year":"2024","journal-title":"Int J Surg"},{"issue":"6","key":"10.1016\/j.jhepr.2025.101704_bib167","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/jamasurg.2024.0520","article-title":"US liver transplant outcomes after normothermic regional perfusion vs standard super rapid recovery","volume":"159","author":"Brubaker","year":"2024","journal-title":"JAMA Surg"},{"issue":"3","key":"10.1016\/j.jhepr.2025.101704_bib168","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1001\/jamasurg.2021.6781","article-title":"Impact of portable normothermic blood-based machine perfusion on outcomes of liver transplant: the OCS liver PROTECT randomized clinical trial","volume":"157","author":"Markmann","year":"2022","journal-title":"JAMA Surg"},{"issue":"5","key":"10.1016\/j.jhepr.2025.101704_bib169","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.jhep.2023.05.027","article-title":"Machine perfusion techniques for liver transplantation - a meta-analysis of the first seven randomized-controlled trials","volume":"79","author":"Parente","year":"2023","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.jhepr.2025.101704_bib170","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.jhep.2018.12.013","article-title":"Normothermic regional perfusion vs. super-rapid recovery in controlled donation after circulatory death liver transplantation","volume":"70","author":"Hessheimer","year":"2019","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.jhepr.2025.101704_bib171","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jhep.2021.10.004","article-title":"A multicentre outcome analysis to define global benchmarks for donation after circulatory death liver transplantation","volume":"76","author":"Schlegel","year":"2022","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.jhepr.2025.101704_bib172","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1097\/HEP.0000000000000363","article-title":"Acute rejection after liver transplantation with machine perfusion versus static cold storage: a systematic review and meta-analysis","volume":"78","author":"Maspero","year":"2023","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.jhepr.2025.101704_bib173","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1001\/jamasurg.2024.6520","article-title":"Improved outcomes and resource use with normothermic machine perfusion in liver transplantation","volume":"160","author":"Nguyen","year":"2025","journal-title":"JAMA Surg"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555925003878?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555925003878?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T11:24:07Z","timestamp":1777634647000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589555925003878"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":173,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S2589555925003878"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2025.101704","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Steatotic liver disease and liver transplantation: Candidate selection and post-transplant management","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2025.101704","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"101704"}}